NCT02842125 2020-06-02
Safety and Efficacy of Intra-Arterial and Intra-Tumoral Ad-p53 With Capecitabine (Xeloda) or Anti-PD-1 in Liver Metastases of Solid Tumors and Recurrent Head and Neck Squamous Cell Cancer
MultiVir, Inc.
Phase 1/2 Terminated
Clinical Trials
3 trialsNCT00003257 2013-12-04
Gene Therapy in Treating Patients With Recurrent Head and Neck Cancer
National Cancer Institute (NCI)
Phase 2 Unknown
NCT00017173 2012-06-14
S0011, Gene Therapy & Surgery Followed by Chemo & RT in Newly Diagnosed Cancer of the Mouth or Throat
SWOG Cancer Research Network
Phase 2 Terminated